Sugawara S. 1992. Biotech firms forming more strategic links: Young industry seeks support from mature corporations. October 19. Washington Post, Washington Business: p. 1.

Technology Management Group. 1993. Human Vaccine III. New Haven, Connecticut.


UNICEF. 1991a. Executive Board Action Item: Establishment of a Vaccine Independence Initiative. March 12. New York, New York.

UNICEF. 1991b. Executive Board: Universal Childhood immunization, 1990, Progress Report. March 20. New York, New York.

UNICEF. 1992a. Vaccine Independence Initiative. Project Proposal for Funding by Interested Donors. July 13. New York, New York.

UNICEF. 1992b. Data regarding volume and price of purchased vaccines. Vaccine Supply Division. New York, New York.

U.S. Congress, House. 1986. Childhood Immunizations. A Report prepared by the Subcommittee on Health and the Environment, Committee on Energy and Commerce. September. Washington, D.C.

U.S. Congress, Senate. 1982. Heating to Review Federal and State Expenditures for the Purchase of Children's Vaccines. Subcommittee on Investigations and General Oversight, Committee on Labor and Human Resources, July 22, Washington, D.C.

U.S. Department of Health and Human Services. 1991. Establishments and Products Licensed under Section 351 of the Public Health Service Act. March 1. Rockville, Maryland: U.S. Food and Drug Administration.


Vandersmissen W. 1992. Availability of quality vaccines: The industrial point of view. Vaccine 10:955–957.


Williams D. 1993. Testimony before the Subcommittee on Access to Immunization Services, National Vaccine Advisory Committee. A Public Hearing on the Economic and Commercial Underpinning of Vaccine Supply, February 24, Bethesda, Maryland.

World Almanac and Book of Facts. 1992. New York, New York: Pharos Books.

World Bank. 1993. World Development Report: Investing in Health. Washington, D.C.

World Health Organization. 1992. EPI for the 1990s. Geneva.

World Health Organization/Children's Vaccine Initiative. 1992a. CVI Forum. October. Geneva.

World Health Organization/Children's Vaccine Initiative. 1992b. Report of Second Meeting of the Consultative Group. November 16–17. Geneva.

World Health Organization/Children's Vaccine Initiative. 1992c. Task Force on Situation Analysis. November 16–17. Geneva.


Zoon KC Beatrice MG. 1993. New directions for FDA's Center for Biologics Evaluation and Research (CBER). New Drug Approvals in 1992. February. Washington, D.C.: Pharmaceutical Manufacturers Association.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement